BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis, and biological evaluation of N-arylpiperazine derivatives as interferon inducers. 2020

Yeonjeong Chu, and B Raja Sekhara Reddy, and V Pratap Reddy Gajulapalli, and K Sudhakar Babu, and Eunha Kim, and Sanghee Lee
Brain Science Institute, Korea Institute of Science and Technology, Seoul, South Korea; Department of Molecular Science and Technology, Ajou University, Suwon, South Korea.

Type I Interferon (IFN) signaling plays an important role in the immune defense system against virus infection and in the innate immune response, thus IFNs are widely used as anti-viral agents and treatment for immune disorder or cancer. However, there is a growing demand for novel small-molecule IFN inducer due to tolerance, toxicity, or short duration of action following direct administration of IFNs. In this study, we assessed arylpiperazine (ARP) as a new core skeleton of IFN inducer. To investigate structure-activity relationship, we designed and synthesized a series of ARP analogues and evaluated the ability to stimulate IFN response in THP-1 human monocyte cells. Compound 5i was identified as a potent type I IFN inducer as it significantly increased cytokine secretion and increased expression of various IFN-stimulating genes which are representative biomarkers of type I IFN pathway. Our results suggested a beneficial therapeutic potential of 5i as an anti-viral agent.

UI MeSH Term Description Entries
D007113 Immunity, Innate The capacity of a normal organism to remain unaffected by microorganisms and their toxins. It results from the presence of naturally occurring ANTI-INFECTIVE AGENTS, constitutional factors such as BODY TEMPERATURE and immediate acting immune cells such as NATURAL KILLER CELLS. Immunity, Native,Immunity, Natural,Immunity, Non-Specific,Resistance, Natural,Innate Immune Response,Innate Immunity,Immune Response, Innate,Immune Responses, Innate,Immunity, Non Specific,Innate Immune Responses,Native Immunity,Natural Immunity,Natural Resistance,Non-Specific Immunity
D007369 Interferon Inducers Agents that promote the production and release of interferons. They include mitogens, lipopolysaccharides, and the synthetic polymers Poly A-U and Poly I-C. Viruses, bacteria, and protozoa have been also known to induce interferons. Inducers, Interferon
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000074084 THP-1 Cells A human leukemia monocytic cell line derived from a patient with LEUKEMIA, MONOCYTIC, ACUTE. It is used as a model to study the function of MONOCYTES and MACROPHAGES, their signaling pathways, nutrient and drug transport. THP-1 Cell Line,Cell Line, THP-1,Cell Lines, THP-1,Cell, THP-1,Cells, THP-1,THP 1 Cell Line,THP 1 Cells,THP-1 Cell,THP-1 Cell Lines
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Yeonjeong Chu, and B Raja Sekhara Reddy, and V Pratap Reddy Gajulapalli, and K Sudhakar Babu, and Eunha Kim, and Sanghee Lee
Scutellarin derivatives as apoptosis inducers: Design, synthesis and biological evaluation.
July 2017, European journal of medicinal chemistry,
Yeonjeong Chu, and B Raja Sekhara Reddy, and V Pratap Reddy Gajulapalli, and K Sudhakar Babu, and Eunha Kim, and Sanghee Lee
Design, synthesis and biological evaluation of some novel sulfonamide derivatives as apoptosis inducers.
July 2017, European journal of medicinal chemistry,
Yeonjeong Chu, and B Raja Sekhara Reddy, and V Pratap Reddy Gajulapalli, and K Sudhakar Babu, and Eunha Kim, and Sanghee Lee
Synthesis and biological evaluation of N-phosphoryl dipeptide derivatives as potent apoptosis inducers.
January 2008, Protein and peptide letters,
Yeonjeong Chu, and B Raja Sekhara Reddy, and V Pratap Reddy Gajulapalli, and K Sudhakar Babu, and Eunha Kim, and Sanghee Lee
Design, synthesis and biological evaluation of some novel quinazolinone derivatives as potent apoptotic inducers.
May 2018, Future medicinal chemistry,
Yeonjeong Chu, and B Raja Sekhara Reddy, and V Pratap Reddy Gajulapalli, and K Sudhakar Babu, and Eunha Kim, and Sanghee Lee
Design and synthesis of N-acyl and dimeric N-Arylpiperazine derivatives as potential antileishmanial agents.
August 2023, Bioorganic chemistry,
Yeonjeong Chu, and B Raja Sekhara Reddy, and V Pratap Reddy Gajulapalli, and K Sudhakar Babu, and Eunha Kim, and Sanghee Lee
Synthesis and biological evaluation of novel 9-substituted-8-hydroxyadenine derivatives as potent interferon inducers.
March 2006, Journal of medicinal chemistry,
Yeonjeong Chu, and B Raja Sekhara Reddy, and V Pratap Reddy Gajulapalli, and K Sudhakar Babu, and Eunha Kim, and Sanghee Lee
Design, synthesis, crystal structure, biological evaluation and molecular docking studies of carbazole-arylpiperazine derivatives.
November 2016, Bioorganic & medicinal chemistry,
Yeonjeong Chu, and B Raja Sekhara Reddy, and V Pratap Reddy Gajulapalli, and K Sudhakar Babu, and Eunha Kim, and Sanghee Lee
Design, synthesis and biological evaluation of new arylpiperazine derivatives bearing a flavone moiety as α1-adrenoceptor antagonists.
February 2011, Bioorganic & medicinal chemistry letters,
Yeonjeong Chu, and B Raja Sekhara Reddy, and V Pratap Reddy Gajulapalli, and K Sudhakar Babu, and Eunha Kim, and Sanghee Lee
Synthesis, biological evaluation and SAR of naftopidil-based arylpiperazine derivatives.
May 2018, Bioorganic & medicinal chemistry letters,
Yeonjeong Chu, and B Raja Sekhara Reddy, and V Pratap Reddy Gajulapalli, and K Sudhakar Babu, and Eunha Kim, and Sanghee Lee
Synthesis and biological evaluation of arylpiperazine derivatives as potential anti-prostate cancer agents.
January 2019, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!